813 related articles for article (PubMed ID: 9065997)
1. Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy.
Makris M; Greaves M; Phillips WS; Kitchen S; Rosendaal FR; Preston EF
Thromb Haemost; 1997 Mar; 77(3):477-80. PubMed ID: 9065997
[TBL] [Abstract][Full Text] [Related]
2. Warfarin-reversal: results of a phase III study with pasteurised, nanofiltrated prothrombin complex concentrate.
Pabinger-Fasching I
Thromb Res; 2008; 122 Suppl 2():S19-22. PubMed ID: 18549908
[TBL] [Abstract][Full Text] [Related]
3. Retrospective evaluation of a method to predict fresh-frozen plasma dosage in anticoagulated patients.
Frazee LA; Bourguet CC; Gutierrez W; Elder-Arrington J; Elackattu AE; Haller NA
Am J Ther; 2008; 15(2):111-8. PubMed ID: 18356630
[TBL] [Abstract][Full Text] [Related]
4. Warfarin-induced bleeding complications - clinical presentation and therapeutic options.
Wiedermann CJ; Stockner I
Thromb Res; 2008; 122 Suppl 2():S13-8. PubMed ID: 18549907
[TBL] [Abstract][Full Text] [Related]
5. Prothrombin complex concentrate (Octaplex) in patients requiring immediate reversal of oral anticoagulation.
Riess HB; Meier-Hellmann A; Motsch J; Elias M; Kursten FW; Dempfle CE
Thromb Res; 2007; 121(1):9-16. PubMed ID: 17407788
[TBL] [Abstract][Full Text] [Related]
6. Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature.
Leissinger CA; Blatt PM; Hoots WK; Ewenstein B
Am J Hematol; 2008 Feb; 83(2):137-43. PubMed ID: 17729241
[TBL] [Abstract][Full Text] [Related]
7. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
Yasaka M; Sakata T; Naritomi H; Minematsu K
Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of a prothrombin complex concentrate (Octaplex) for rapid reversal of oral anticoagulation.
Lubetsky A; Hoffman R; Zimlichman R; Eldor A; Zvi J; Kostenko V; Brenner B
Thromb Res; 2004; 113(6):371-8. PubMed ID: 15226091
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves.
Yiu KH; Siu CW; Jim MH; Tse HF; Fan K; Chau MC; Chow WH
Am J Cardiol; 2006 Feb; 97(3):409-11. PubMed ID: 16442406
[TBL] [Abstract][Full Text] [Related]
10. Management of excessive anticoagulation or bleeding.
Makris M
Semin Vasc Med; 2003 Aug; 3(3):279-84. PubMed ID: 15199461
[TBL] [Abstract][Full Text] [Related]
11. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; ViganĂ² D'Angelo S
Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
[TBL] [Abstract][Full Text] [Related]
12. Rapid Warfarin reversal in the setting of intracranial hemorrhage: a comparison of plasma, recombinant activated factor VII, and prothrombin complex concentrate.
Woo CH; Patel N; Conell C; Rao VA; Faigeles BS; Patel MC; Pombra J; Akins PT; Axelrod YK; Ge IY; Sheridan WF; Flint AC
World Neurosurg; 2014 Jan; 81(1):110-5. PubMed ID: 23220122
[TBL] [Abstract][Full Text] [Related]
13. A comparative study of prothrombin complex concentrates and fresh-frozen plasma for warfarin reversal under static and flow conditions.
Ogawa S; Szlam F; Ohnishi T; Molinaro RJ; Hosokawa K; Tanaka KA
Thromb Haemost; 2011 Dec; 106(6):1215-23. PubMed ID: 22071880
[TBL] [Abstract][Full Text] [Related]
14. PPSB as first choice treatment in the reversal of oral anticoagulant therapy.
Strengers PF; Drenth JC
Acta Anaesthesiol Belg; 2002; 53(3):183-6. PubMed ID: 12461827
[TBL] [Abstract][Full Text] [Related]
15. Prothrombin complex concentrates to reverse warfarin-induced coagulopathy in patients with intracranial bleeding.
Cabral KP; Fraser GL; Duprey J; Gibbons BA; Hayes T; Florman JE; Seder DB
Clin Neurol Neurosurg; 2013 Jun; 115(6):770-4. PubMed ID: 22835715
[TBL] [Abstract][Full Text] [Related]
16. Prothrombin complex concentrate versus standard therapies for INR reversal in trauma patients receiving warfarin.
Chapman SA; Irwin ED; Beal AL; Kulinski NM; Hutson KE; Thorson MA
Ann Pharmacother; 2011 Jul; 45(7-8):869-75. PubMed ID: 21775690
[TBL] [Abstract][Full Text] [Related]
17. Correction of coagulopathy in warfarin associated cerebral hemorrhage.
Aiyagari V; Testai FD
Curr Opin Crit Care; 2009 Apr; 15(2):87-92. PubMed ID: 19300085
[TBL] [Abstract][Full Text] [Related]
18. Pharmacologic interventions for reversing the effects of oral anticoagulants.
Kalus JS
Am J Health Syst Pharm; 2013 May; 70(10 Suppl 1):S12-21. PubMed ID: 23640528
[TBL] [Abstract][Full Text] [Related]
19. [-Anticoagulant drugs-].
Gulba DC
Herz; 1996 Feb; 21(1):12-27. PubMed ID: 8647576
[TBL] [Abstract][Full Text] [Related]
20. Factors associated with failure to correct the international normalised ratio following fresh frozen plasma administration among patients treated for warfarin-related major bleeding. An analysis of electronic health records.
Menzin J; White LA; Friedman M; Nichols C; Menzin J; Hoesche J; Bergman GE; Jones C
Thromb Haemost; 2012 Apr; 107(4):662-72. PubMed ID: 22318400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]